A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]
Vascular
AHA/ASA updates stroke treatment guidelines
The American Heart Association/American Stroke Association said today that it updated its treatment guidelines for patients suffering from ischemic stroke to include endovascular treatments. The decision supports the use of stent retrieval, and other thrombectomy devices, used to remove clots in patients who have obstructions in the large arteries supplying blood to the brain according […]
Bard touts publication of Lutonix study in NEJM
C.R. Bard (NYSE:BCR) said last Thursday that a 2-year study of its Lutonix drug-coated balloon catheter was published in The New England Journal of Medicine. The 2-year Levant 2 study data showed non-inferiority of the device and a trend towards superiority, compared to standard percutaneous transluminal angioplasty, in the treatment of peripheral artery disease, the company said. “We want to thank […]
Kips Bay Medical pulls the plug
Kips Bay Medical (OTC:KIPS) said last week it will be liquidating the company after terminating the Emesh I clinical feasibility trial of its eSVS mesh based on poor 6-month results. The company’s board of directors unanimously approved a plan to dissolve the company and return any remaining cash to its stockholders, Minneapolis, Minn.-based Kips Bay said. Kips […]
Medtronic touts 5-year Endurant AAA stent data
Medtronic (NYSE:MDT) said its Endurant abdominal aortic aneurysm stent is performing well, according to a 5-year follow-up study of the device. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago last Saturday. The 5-year, 150-patient study data reported a 99.2% freedom from aneurysm related mortality and an 89% freedom from secondary […]
Two a day: Medtronic acquires Aptus Endo for $110m
Medtronic (NYSE:MDT) announced its 2nd acquisition of the day this afternoon, saying it paid $110 million to acquire Aptus Endosystems and its Heli-FX device aortic securement device. Earlier today the Fridley, Minn.-based medical device giant said it picked up CardioInsight for $93 million. “We are excited to add this unique complementary, anchor technology to our aortic portfolio,” aortic […]
Bard touts 2-year data on Lutonix
C.R. Bard (NYSE:BCR) said that data from a 2-year study of its Lutonix drug-coated balloon catheter showed positive results for the device when compared to standard percutaneous transluminal angioplasty. The 2-year Levant study data showed non-inferiority of the device and a trend towards superiority compared to standard PTA, the company said. Composite safety scores at […]
Terumo launches peripheral stent in U.S.
Terumo (TYO:4543) said today that it launched the Misago RX self-expanding peripheral stent in the U.S. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago. The stent is designed to treat patients with peripheral artery disease in the superficial femoral artery or proximal popliteal artery, the Tokyo-based company said. “The Misago stent […]
Medtronic launches Fortrex PTA balloon catheter in US
Medtronic (NYSE:MDT) said yesterday that it launched its Fortrex percutaneous transluminal angioplasty balloon catheter in the U.S. The Fortrex is designed to treat peripheral artery disease and maintain arteriovenous access for hemodialysis, the Fridley, Minn.-based company said. The catheter uses a balloon to break up plaque blockages in the peripheral vascular system, or blockages in hemodialysis […]
Cordis releases expanded range of CTO treatment catheters
Cordis Corporation said Monday it is releasing an expanded line of catheters designed to treat and cross chronic total occlusions. The previous Johnson & Johnson (NYSE:JNJ) subsidiary, recently sold to Cardinal Health (NYSE:CAH) said it will bring the Outback Elite re-entry catheter to the U.S., Japan and Europe, and the Elitecross Support catheter to the U.S. “New and […]
UPDATE: Baxter recalls Vascu-Guard patches in FDA Class I recall
UPDATED June 5, 2015, with details from the FDA. Baxter (NYSE:BAX) said this week that it’s recalling its Vascu-Guard peripheral vascular patches packaged under 4 specific product codes. The company began notifying customers May 2. The FDA has labeled it as a Class I recall, the most serious type of recall issued by the federal watch […]
